Lemme Reset (formerly GLP-1 Daily) review

Our take: the right doses, sold on the wrong mechanism

Lemme GLP-1 Daily is the supplement most people mean when they say "GLP-1 supplement". It launched in September 2024 from the brand co-founded by Kourtney Kardashian Barker, sold at around $90 a month as a natural route to the hormone behind Ozempic, and has since been renamed Lemme Reset with, the brand's retail partners say, the same formula.

Credit first, because it is rare. The label names three branded extracts, quantifies every one, and puts each at the amount used in its own published trial. By the standards of this aisle — where our reviews regularly find one disclosed dose out of five or no doses at all — that is a genuinely good label, and it earns one of the highest dose scores we have given.

The problem is the word on the front. The ingredient that carries the GLP-1 claim is Eriomin, a lemon extract. In its trial, GLP-1 rose by about 15 per cent in people with prediabetes — and the authors reported that neither Eriomin nor placebo changed any body measurement. The GLP-1 went up. The weight did not move. The weight evidence in this capsule comes from the other two ingredients, which do not claim to work through GLP-1 at all.

That gap is what two sets of class actions are now about. It is also why we would describe this product very differently from its packaging: a reasonably evidenced appetite-and-fat-loss formula with modest effects, rather than a GLP-1 supplement. At $80 a bottle it is a lot to pay for that, and far less than the drugs deliver.

This is a desk review of a published label and the research behind each ingredient. Nobody here has taken it.

What is in the capsule

A serving is two capsules, and a bottle holds 30 servings. Lemme's panel lists:

• Eriomin lemon fruit extract, 200 mg — standardised to 70 per cent eriocitrin, a citrus flavonoid.
• Supresa saffron extract, 176.5 mg — from saffron stigma, standardised to 0.3 per cent safranal.
• Morosil red orange fruit extract, 400 mg — from Moro blood oranges, standardised to 0.8 per cent anthocyanins.

The other ingredients are organic rice hulls and a hypromellose capsule. The directions are two capsules daily with food, and the brand recommends three to six months of consistent use.

Two things on the page are worth reading together. The bottle says it supports "GLP-1 production & weight management". A footnote on the same page says Lemme Reset is not a weight loss supplement and is formulated to support healthy weight management, and another says it does not contain GLP-1 and is not a GLP-1 agonist drug. The distinction between weight loss and weight management is a legal one rather than one a shopper is likely to notice.

The GLP-1 ingredient: GLP-1 up, weight unchanged

Eriomin's key trial, published in Phytotherapy Research in 2019, randomised 103 people with prediabetes to placebo or 200, 400 or 800 mg of Eriomin a day for 12 weeks. All three doses had similar effects: blood glucose fell about 5 per cent, insulin resistance about 7 per cent, HbA1c about 2 per cent, and GLP-1 rose about 15 per cent, with adiponectin up 19 per cent. The authors report that 24 per cent of participants were no longer classed as prediabetic.

Then the sentence that matters for a weight-loss buyer: Eriomin or placebo did not influence the anthropometric and dietary variables. That covers weight, BMI and body measurements, and what people ate.

So the trial is real, the dose on Lemme's label matches it, and the GLP-1 rise is a measured result rather than a marketing inference. It is a result in people with prediabetes, which most buyers do not have. And it shows the limit of the whole "boost your own GLP-1" idea: nudging a hormone that the body breaks down within about two minutes is not the same as the drugs, which hold the signal open for a week. Our GLP-1 explainer goes through why.

The appetite ingredient: one small, older trial

Supresa is sold by PLT Health, which presents a 2010 study of Satiereal — a saffron extract from the same French developer, at the same 176.5 mg daily dose — as Supresa's clinical study. That trial, in Nutrition Research, randomised 60 mildly overweight women to the extract or placebo for eight weeks, with no calorie restriction.

It reported significantly greater weight reduction than placebo and fewer snacking episodes, recorded by the women in food diaries. The abstract does not state the size of the weight difference. Lemme's page quotes the study's secondary findings — 69 per cent felt less hungry, 55 per cent fewer snacking events — which are self-reported measures from 31 women on the extract.

It is a genuine placebo-controlled result, and it is small, short, run by a contract research firm for the ingredient's developer, and sixteen years old. Useful as a signal; thin as a foundation.

The fat-loss ingredient: the strongest trial, with a big dropout

Morosil has the most substantial evidence of the three. A 2022 trial in Nutrients randomised 180 overweight adults to 400 mg of Morosil a day or placebo for six months, alongside a calorie-controlled diet and a walking programme. The Morosil group lost 4.2 per cent of body weight against 2.2 per cent on placebo, with larger reductions in waist and hip circumference and in visceral and subcutaneous fat.

Three caveats come with it. Only 98 of the 180 finished — 45 on Morosil and 53 on placebo — which is a high dropout for a six-month study and makes the completers a selected group. Everyone was also dieting and exercising, so the result is an add-on to a programme rather than an effect on its own. And the trial was funded by Bionap, which makes Morosil.

A two-percentage-point difference over six months is a real, modest effect. For someone weighing 90 kg, it is about 1.8 kg. For scale, semaglutide produced about 15 per cent in STEP 1 and tirzepatide 20.9 per cent in SURMOUNT-1.

What nobody has tested

There is no published trial of Lemme GLP-1 Daily or Lemme Reset itself. The "clinically studied" language on the page refers to three separate ingredient trials, in three different populations — women who snack, adults on a diet, people with prediabetes — over eight weeks, twelve weeks and six months. Whether the three together do more than the best of them alone, or anything different, is unknown.

That is a common pattern in this aisle, and Lemme handles it better than most, because at least each trial's dose is honoured. But "three clinically studied ingredients" is not the same claim as "a clinically studied product", and the page is careful never to say the second.

The lawsuits

Two proposed class actions titled Robins v. Lemme were filed in 2025 — in California state court in February and in federal court in New York in March. They argue that there is no clinical evidence that simply boosting the body's own GLP-1 produces sustained weight loss, that single-ingredient studies do not substantiate the combined formula, and that the named plaintiff gained weight while taking it. A Lemme spokesperson called the case frivolous.

A further case, Tiberia v. Lemme, was filed in federal court in the Central District of California on 13 July 2026. According to reporting on the complaint, it focuses on the Eriomin evidence: a GLP-1 increase, but no change in weight, BMI or fat mass. It also notes the rename to Lemme Reset with the same formula.

These are allegations. We could not find a ruling on the merits in any of them. They are worth knowing about because the central argument is the same one this review arrives at independently from the published trials.

Price, and what you are paying for

On 25 September 2026 Lemme's own store listed a bottle at $80 bought once, or $64 a month on subscription, with larger discounts on two- and three-month deliveries and a sitewide sale running. That is $2.67 a day, or $2.13 on a monthly subscription. Earlier coverage and the lawsuits quote $89.99.

For comparison, Life Extension sells the saffron extract on its own, as Satiereal at 156 mg a day, for $27 a month — about $0.90 a day. Morosil and Eriomin are also sold as single-ingredient supplements. Lemme's price is not an extreme markup for three branded extracts at full doses. What you are paying extra for is the combination, and the combination is the one thing nobody has tested.

The return terms are narrow. In the US, Lemme offers a money-back guarantee on your first single-bottle order only, minus a $9.99 processing fee; multi-bottle orders cannot be returned, and international orders are final.

Ratings split sharply by venue. The brand's own site showed 4.3 out of 5 across 1,190 reviews. The original GLP-1 Daily listing on Amazon showed 3.5 across 736 ratings, with 24 per cent at one star, and was marked currently unavailable when we checked.

Side effects and who should check first

The three extracts were well tolerated in their trials at these doses, and the Morosil trial reported liver safety markers within the normal range throughout. Lemme's FAQ mentions only an adjustment period.

Two groups should ask before starting. Eriomin lowered blood glucose in its trial, so anyone on diabetes medicines — especially insulin or a sulfonylurea — should check with their prescriber, and Lemme's own page says to consult a practitioner if you have low blood sugar. Pregnancy and breastfeeding are reasons to ask a practitioner first, as Lemme itself advises. If you are taking a prescription GLP-1 drug, there is no reason to add this, and no evidence about combining them.

Sources and shopping: what to check before buying

Lemme Reset is sold on Lemme's own site and, according to legal reporting, through Target, Walmart and Ulta Beauty. The original GLP-1 Daily listing on Amazon was unavailable when we checked. We have no commercial link for it, so this page carries no buy button.

• Confirm the panel matches the three amounts above — 200 mg, 176.5 mg and 400 mg — whichever name is on the bottle.
• Budget from the subscription price, and read the cancellation terms before starting one.
• If you want to test it, buy a single bottle first: the refund only covers the first one.
• Judge it on appetite and snacking over two to three months, not on GLP-1, which you cannot measure at home.

If what you want is the best-evidenced product sold on a GLP-1 mechanism, our Calocurb review covers the one supplement in this aisle with trials measuring both the hormones and the weight, on the actual extract. It costs more. It is also the only one we have found where the GLP-1 claim and the weight claim come from the same study.